Smoke-Evacuating Trocars Market to Reach USD 810.0 Million by 2036, India – CAGR 11.8%,

Smoke-Evacuating Trocars Market

Growing emphasis on surgical smoke control and source-level plume capture is driving adoption of integrated smoke-evacuating trocars across laparoscopic procedures

Rockville, Maryland — September 24, 2026 — Demand for smoke-evacuating trocars is projected to increase from USD 315.0 million in 2026 to USD 810.0 million by 2036, advancing at a 9.9% CAGR during the forecast period. Growth is being supported by increasing adoption of source-level smoke capture during laparoscopic procedures, expanding requirements for surgical plume management, and demand for solutions that maintain clear visualization without disrupting operating-room workflows.

Electrosurgical and energy-based procedures can generate surgical smoke that accumulates within the operative field. As hospitals place greater emphasis on smoke management, smoke-evacuating trocars are gaining attention as a way to capture plume at its source while supporting established laparoscopic access procedures.

Get detailed market forecasts, competitive benchmarking, and pricing trends:

Integrated Smoke Trocars Lead Product Demand

Integrated smoke trocars are projected to account for 38.0% of the market in 2026, making them the leading product type.

These systems combine laparoscopic access and smoke capture within a single device. By integrating the evacuation function into the trocar, they can reduce separate tubing connections and simplify the steps involved in smoke removal.

Maintaining pneumoperitoneum is another important consideration during minimally invasive surgery. Integrated designs are intended to support smoke evacuation while preserving port stability and minimizing disruption to the established laparoscopic setup.

Ambulatory surgical centers are also showing interest in solutions that can connect directly to existing suction infrastructure. Such configurations can reduce the need for additional equipment towers and allow facilities to incorporate smoke management into existing operating-room arrangements.

Surgical Smoke Management Supports Adoption

Hospitals are increasingly incorporating smoke removal into surgical safety and operating-room protocols. Expanding legislation and institutional requirements in some markets are also contributing to demand for smoke-evacuation technologies.

For surgeons, smoke accumulation can affect visualization during energy-based laparoscopic procedures. Maintaining a clear operative field can therefore be an important workflow consideration, particularly during procedures involving sustained use of electrosurgical devices.

The growing emphasis on source-level capture is encouraging manufacturers to develop trocars capable of combining access, insufflation compatibility, and smoke evacuation within a streamlined platform.

India Records Fastest Country-Level Growth

India is projected to record the fastest growth at a CAGR of 11.8% through 2036. Expansion of private hospitals and increasing laparoscopic procedure capacity are supporting demand for smoke-evacuation solutions.

Cost considerations remain important for healthcare buyers in the country. Some facilities may initially adopt adapter-based smoke-evacuation systems before transitioning toward fully integrated trocar solutions as procedure volumes and smoke-management requirements increase.

The United States is forecast to expand at a 10.0% CAGR through 2036. Smoke-evacuation legislation is strengthening the role of compliance in purchasing decisions, encouraging hospitals to consider products that can connect efficiently with existing suction infrastructure.

The ability to incorporate smoke removal without significant changes to operating-room equipment is an important consideration for healthcare facilities seeking practical solutions for laparoscopic procedures.

Germany is projected to advance at a 9.5% CAGR during the forecast period. Structured hospital procurement and high laparoscopic procedure intensity are supporting steady demand.

Rather than requiring broad equipment replacement, smoke-control technologies can increasingly be incorporated into routine surgical workflow planning. This creates opportunities for manufacturers offering systems compatible with established laparoscopic access and suction infrastructure.

Competitive Landscape

The competitive landscape includes major medical device companies such as Medtronic, CONMED, Stryker, and CooperSurgical.

These companies participate across areas including laparoscopic access platforms, insufflation systems, and smoke-control technologies. Competition is focused on providing plume-removal capabilities while maintaining port stability and minimizing disruption to surgical procedures.

Product compatibility is an important consideration as hospitals seek to integrate smoke evacuation into existing operating-room infrastructure. Manufacturers that can support established suction connections and laparoscopic workflows have opportunities to address demand from both hospitals and ambulatory surgical centers.

Unlock Actionable Insights from the Complete Report: 

Market Outlook

The smoke-evacuating trocars market is projected to grow from USD 315.0 million in 2026 to USD 810.0 million by 2036, representing a global CAGR of 9.9%.

India, the United States, and Germany are projected to record CAGRs of 11.8%, 10.0%, and 9.5%, respectively. Integrated smoke trocars are expected to remain the leading product type, accounting for 38.0% of the market in 2026.

The combination of surgical smoke-management requirements, expanding laparoscopic procedure volumes, and demand for streamlined operating-room workflows is expected to support continued adoption of smoke-evacuating trocars through 2036.

For detailed segment forecasts, country-level projections, competitive benchmarking, and pricing trends, explore the complete Fact.MR report on the Smoke-Evacuating Trocars Market.

Explore More Related Studies Published by Fact.MR Research

Laryngeal Stents Market

Uveal Melanoma Treatment Market

Laser Cancer Therapy Market

About Fact.MR

Fact.MR is a global market research and consulting firm trusted by Fortune 500 companies and emerging businesses for reliable market intelligence and strategic insights. With a presence across the U.S., UK, India, and Dubai, the company delivers data-driven research and tailored consulting solutions across more than 30 industries and 1,000 markets. Backed by research expertise and advanced analytics, Fact.MR helps organizations evaluate opportunities, understand competitive environments, reduce risks, and make informed business decisions.

Contact Us
11140 Rockville Pike, Suite 400
Rockville, MD 20852, United States
Tel: +1 (628) 251-1583
[email protected]

 

FMI

FMI

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favour the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.